buying opportunity of the year
Sentiment: Strong Buy
agree.brilliant move from elan.biogen will never recover this money.
really! dude-elan has no other drug going for it. they are out of business.
JNJ may be selling out their position. They have no strategic interest in ELN at this point. This may have created an oversold position since they owned around 17% of the shares.